Antithrombotic strategies in COVID-19 disease.

14 March 2021 (08:39 - 08:47)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Serdar Farhan

Lenox Hill Heart and Vascular Institute, New York (United States of America)

4 More presentations in this session

Presentation thumbnail

COVID-19: implications for prehospital, emergency and hospital care in patients with acute coronary syndromes – the European perspective.

Professor K. Huber (Vienna, AT)

Presentation thumbnail

COVID-19: implications for prehospital, emergency and hospital care in patients with acute coronary syndromes – the North American perspective.

Professor J. Katz (New York, US)

Presentation thumbnail

Myocarditis in COVID-19: a matter of (right) definition.

Professor G. Tavazzi (Pavia, IT)

Presentation thumbnail

And then, there was only COVID-19, a transatlantic view on a common enemy - Discussion.

Access the full session

Session thumbnail

And then, there was only COVID-19, a transatlantic view on a common enemy.

The Event

ACVC 2021

14 March 2021 08:39 CET

You may be interested in

Congress Presentation

Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study

26 August 2022

Webinar

Are NOACs already outdated? New trends in anticoagulation therapy

12 December 2022

Webinar

Cardiovascular involvement in COVID-19 patients: multimodality imaging for diagnosis, risk stratification and management

10 June 2021

Congress Presentation

Adjudicated thrombotic events in a cotemporary multicenter cohort of patients with COVID-19: findings from the CORONA-VTE Registry

28 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources